Drug intelligence / Profile preview

fecal microbiota transplant (Hvidovre University Hospital)

Development stage: Unknown
Lead developer: Copenhagen University Hospital Hvidovre
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral, Rectal

Overview

Fecal microbiota transplant (Hvidovre University Hospital) is an investigational microbiome-based therapy being developed by Copenhagen University Hospital Hvidovre for the treatment of anorexia nervosa. [1] This therapy involves the transplantation of fecal microbiota from healthy donors into patients. The underlying hypothesis is that prolonged undernutrition in anorexia nervosa leads to a dysbiotic gut microbiome that perpetuates the disease, and that transplanting a healthy microbiome can help 'reboot' the gut-brain-axis to improve clinical outcomes. [1, 6] The therapy is being studied in the 'ReBoot: FMT in Anorexia Nervosa' trial (NCT05834010), an open-label, non-randomized feasibility study in adult women. [2, 7] Administration is either oral via capsules or as a rectal enema. [2] A publication from January 2026 reported that the single FMT treatment was feasible and safe, successfully shifting the gut bacteria profile toward that of the donor and improving stool consistency. [7, 9]

Other names: fecal microbiota transplantFMTfecal microbiome transplant

Beyond the preview

Go deeper on fecal microbiota transplant (Hvidovre University Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fecal microbiota transplant (Hvidovre University Hospital).

Explore the full profile